This product includes the webinar and CME/CMLE credit.


In this webinar, Dr. Tracy George will discuss updates in the classification of myeloproliferative neoplasms, also including eosinophilic neoplasms with recurring mutations, and mastocytosis. This includes new criteria for accelerated phase (response-to-TKI criteria) in chronic myeloid leukemia, WHO 2016 criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis, as well as eosinophilic neoplasms with and without recurring mutations. Updates in the diagnosis of mastocytosis, now its own chapter again in the WHO 2016 classification, will also be explained.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


Speaker: Tracy I. George, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: March 1, 2021

Maximum CME/CMLE credit available: 1.0


How to claim credit: To earn CME/CMLE credit, all learners must watch the webinar and then complete the online survey. To access the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.

AMA PRA Category 1 Credit(s)™

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 


You might also be interested in:

 

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

 

Course Information
Course Date:
March 01, 2018
Course Objectives
  • Recognize neoplastic mast cells in bone marrow.
  • Follow a diagnostic algorithm for eosinophilia.
  • Discuss updated pathologic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
  • Describe provisional criteria for response-to-tyrosine kinase inhibitors in chronic myeloid leukemia.
WHO Update 2016: Myeloproliferative Neoplasms (CE Available)
Speaker Information
Tracy I. George MD  [ view bio ]
Individual topic purchase: Selected
American Medical Association
Continuing Medical Education: 1.00
American Society for Clinical Pathology
CMLE: 1.00
Products
George Presentation (+CME/CMLE)
AMP Regular Member: $5.00
AMP Technologist Member: $5.00
AMP Associate Member: $5.00
Non-member Price: $205.00